Search Results for keywords:"Noramco"

Found 2 results
Skip to main content

Search Results: keywords:"Noramco"

  • Type:Notice
    Citation:89 FR 97071
    Reading Time:about 2 minutes

    Noramco has applied to the Drug Enforcement Administration (DEA) to become an importer of certain controlled substances, including Poppy Straw Concentrate and an intermediate form of Tapentadol. They plan to use these substances to manufacture other drugs for their customers. As part of their application, they also intend to import synthetic cannabidiol and synthetic Tetrahydrocannabinol, while noting that they will not import finished drugs for commercial sale. The public can submit comments or request a hearing on this application by January 6, 2025.

    Simple Explanation

    Noramco wants permission to bring certain special materials into the country to make medicine, but they won't sell these materials as final drugs. People have until January 6, 2025, to say what they think about this idea.

  • Type:Notice
    Citation:90 FR 8153
    Reading Time:about a minute or two

    Noramco has submitted an application to the Drug Enforcement Administration (DEA) to become a registered bulk manufacturer of controlled substances. The company specifically plans to produce active pharmaceutical ingredients, including synthetic marihuana and tetrahydrocannabinols. Individuals or organizations can submit comments or objections to this application by March 25, 2025, through the Federal eRulemaking Portal. The announcement provides further details about the application and the procedures for submitting feedback.

    Simple Explanation

    Noramco wants permission from the US government to make certain special medicine ingredients, like fake marijuana, and people can tell the government if they think it's a good or bad idea until March 25, 2025.